Cited by 400Barrier Structure and Function StudiesDrug Transport and Resistance MechanismsNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.

Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier

Open access

Lajoie, Jason M., Shusta, Eric V.·2015·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev-pharmtox-010814-124852PMC PMC5051266

Open this paper in CoChat — free account Open PDF

Abstract

Biologics are an emerging class of medicines with substantial promise to treat neurological disorders such as Alzheimer's disease, stroke, and multiple sclerosis. However, the blood-brain barrier (BBB) presents a formidable obstacle that appreciably limits brain uptake and hence the therapeutic potential of biologics following intravenous administration. One promising strategy for overcoming the BBB to deliver biologics is the targeting of endogenous receptor-mediated transport (RMT) systems that employ vesicular trafficking to transport ligands across the BBB endothelium. If a biologic is modified with an appropriate targeting ligand, it can gain improved access to the brain via RMT. Various RMT-targeting strategies have been developed over the past 20 years, and this review explores exciting recent advances, emphasizing studies that show brain targeting in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-pharmtox-010814-124852

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Blood–brain barrier delivery
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,035
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., & Terasaki, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07208.x · Cited by 881
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J. M., Prabhu, S., Watts, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002230 · Cited by 794
The blood–brain barrier in health and disease
Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 794
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676

Show all 124 references

Research works printed but not linked: 4

Descamps L, 1996, Am. J. Physiol., 270, H1149
Brooks DA, 2009, Int. J. Clin. Pharmacol. Ther., 47, S9
Kelaita D, 2013, ArmaGen Pipeline
10.1016/j.addr.2003.12.003 · DOI

Sorted by citations

Items 301–400 of 400

Tissue Distribution and Cellular Localization of Gold Nanocarriers with Bound Oligonucleotides
Fatima, N., Akcan, U., Kaya, M., Gromnicova, R., Loughlin, J., Sharrack, B., & Male, D. K. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0469 · Cited by 4
Nanomedicine Applications in Treatment of Primary Central Nervous System Lymphoma: Current State of the Art
Wang, M., Qu, Y., Hu, D., Niu, T., & Qian, Z. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3133 · Cited by 4
Design and Evaluation of RNA Aptamer–Mediated Delivery of C/EBP β siRNA for Oncological Therapy
Vasconcelos, D., Sodergren, M. H., Reebye, V., Vasara, J., Song, M., Holm, K. N., Khorsandi, S. E., Rossi, J. J., Habib, N. A., & Huang, K. (2025) · Journal of Nucleic Acids · doi:10.1155/jna/1461574 · Cited by 3
Identification of Variable Lymphocyte Receptors That Target the Human Blood–Brain Barrier
Katt, M. E., Waters, E. A., Gastfriend, B. D., Herrin, B. R., Cooper, M. D., & Shusta, E. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091179 · Cited by 3
Self-citation
Porcine plasma-derived extracellular vesicles orchestrate multi-target neuroimmune reconfiguration to alleviate Alzheimer’s disease pathology in a 5×FAD mouse model
Lu, X., Jiang, Y., Lin, X., Zhang, Y. X., Liu, Q., & Chen, S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03866-4 · Cited by 3
Nanoparticle targeting strategies for traumatic brain injury
Flores-Prieto, D. E. E., & Stabenfeldt, S. E. (2024) · Journal of Neural Engineering · doi:10.1088/1741-2552/ad995b · Cited by 5
Identifying and Understanding Seizure Liability in Drug Development
Sokolowski, K., Erwin, L. L., Liu, J. S.-H., Authier, S., McMaster, O., Pressly, B., Bolon, B. N., & Delatte, M. S. (2025) · International Journal of Toxicology · doi:10.1177/10915818241307851 · Cited by 3
BIOBASED NANOEMULSION FOR BLOCKING COVID-19 FROM ACCELERATING ALZHEIMER'S DISEASE
D'Arrigo, J. S. (2021) · Juvenis scientia · doi:10.32415/jscientia_2021_7_4_5-11 · Cited by 3
Blood-brain barrier and central nervous system drug delivery: Challenges and opportunities
Bhavsar, N., Saxena, B., & Shah, J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90773-6.00005-1 · Cited by 3
Glioblastoma - Current Evidence
Agrawal, A., & Kunwar, D. S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100846 · Cited by 3
Nanotherapeutics a promising approach for treatment of Parkinson’s disease
Bhalothia, C., & Nagda, G. (2022) · Materials Today Proceedings · doi:10.1016/j.matpr.2022.10.311 · Cited by 4
In-situ Gels for Brain Delivery: Breaching the Barriers
Fatima, G. N., Maurya, P., Nishtha, & Saraf, S. K. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230803114513 · Cited by 4
Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer's diseases
Bhandari, M., Tiwari, R. K., Chanda, S., & Bonde, G. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00003-5 · Cited by 3
Targeted gene delivery through receptors with lipid nanoparticles
Muripiti, V., Velidandia, A., Sharma, Y., Gondru, R., Arya, C. G., & Banothu, J. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105457 · Cited by 3
ApoE potential in CNS drugs targeting and as CNS therapeutic
Ahmed, S., Pande, A. H., & Sharma, S. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00005-4 · Cited by 3
Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors
Mortezaei, N. T., Habibzadeh, A., Rahimian, Z., Boushehri, S., Pourbakhtyaran, E., Savoji, A. B., & Farid, A. S. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_400 · Cited by 3
A Rally for Brain Targeting: The Advent of a New Era
Moghimi, S. M., & Farhangrazi, Z. S. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0063 · Cited by 3
The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics
Tian, M., & Gabathuler, R. (2020) · Neuromethods · doi:10.1007/978-1-0716-0838-8_5 · Cited by 3
Potential of Lipid Based Nanodrug Carriers for Targeted Treatment of Glioblastoma: Recent Progress and Challenges Ahead
Satapathy, B. S., Barik, B., Kumar, L. A., & Biswal, S. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108419 · Cited by 3
Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells
Hudecz, D., Sigurdardóttir, S. B., Christensen, S. C., Hempel, C., Urquhart, A. J., Andresen, T. L., & Nielsen, M. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249686 · Cited by 3
Brain Cancer Receptors and Targeting Strategies
John, R., Vaswani, H., Dandekar, P. P., & Devarajan, P. V. (2019) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-29168-6_2 · Cited by 3
Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endotheliumPreprint
D'Arrigo, J. S. (2017) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/9afh2 · Cited by 3
Construction of Nicotinamide Mononucleotide-Loaded Liposomes and Their In Vitro Transport Across the Blood–Brain Barrier
Wang, T., Wu, Q., Wang, L., Lan, T., Yun, Z., Zhao, L., & Wu, X. (2024) · Applied Sciences · doi:10.3390/app142411732 · Cited by 2
Bacterial infection hypothesis-based therapies for Alzheimer's disease
Teng, M., Ma, R., Liu, S., Zhang, G., Zou, J., & Fu, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.169535 · Cited by 3
Enhanced screening via a pure DNA-encoded peptide library enabled by an Fmoc modification
He, Q., Wang, Y., Tang, X., Zhang, J., Xing, Y., Zong, Z., Elhamouly, M. A., Chen, K., & Chen, S. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524999123 · Cited by 2
Integrative clinical and genomic analyses reveal a causal role of GPNMB in the bone-brain axis of Parkinson’s disease
Guo, X., Wei, P., Shi, W., Zhou, R., & Li, R. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01325-8 · Cited by 2
Effective Brain Targeting Using the Self-Emulsifying Drug Delivery Systems
Gawde, S., Bachhav, Y. G., & Kumar, M. S. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03398-3 · Cited by 2
Liposome-based targeted delivery of anticancer drugs for effective therapy of brain tumors
Shah, M. R., Imran, M. A., & Ullah, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816773-1.00003-1 · Cited by 2
The Roads We Take: Cellular Targets and Pathways Leading Biologics Across the Blood–Brain Barrier
Baghirov, H. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.946045 · Cited by 2
Dimeric Lectin Chimeras as Novel Candidates for Gb3-Mediated Transcytotic Drug Delivery through Cellular Barriers
Xu, M., Antonova, M., Salavei, P., Illek, K., Meléndez, A. V., Omidvar, R., Thuenauer, R., Makshakova, O., & Römer, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010225 · Cited by 2
Recent Advances in Modified Brain‐Targeting Drug Delivery Systems for Erythropoietin
Wang, X., Yao, S., Xiao, J., Li, H., Yang, Q., Li, M., He, Y., Zhang, Y., & Wu, Z. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202200326 · Cited by 2
Using Liposomal and Intranasal Drugs and Pioglitazone for the Treatment and Prevention of Alzheimer’s Disease (Review)
Veselov, V. V., Николаевич, Е. Н., Trukhan, V. M., Zvyagin, A. V., & Nosyrev, A. E. (2023) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-023-02845-w · Cited by 2
Development of transferrin receptor aptamers as drug delivery vehicles for the treatment of brain metastases
Macdonald, J., Mandarano, G., Veedu, R. N., & Shigdar, S. L. (2018) · Own your potential (DEAKIN) · Cited by 2
Treating early dementia: Drug targeting and circumventing the blood-brain barrier
D'Arrigo, J. S. (2018) · Geriatric Medicine and Care · doi:10.15761/gmc.1000111 · Cited by 2
Drug Nanotargeting for Treating Vascular Dementia and Alzheimer's Disease
D'Arrigo Joseph, S. (2021) · Alzheimers Disease & Dementia · doi:10.36959/734/381 · Cited by 2
Surface Active Ligands for Enhanced Brain Targeting of Nanoparticles
Prabakaran, A., Vashist, R., Sangave, S. D., & Alexander, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-2859-6_9 · Cited by 2
Solid lipid nanoparticles-based drug delivery for dementia
Yüksel, N., Bayındır, Z. S., & Amasya, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824331-2.00008-x · Cited by 2
Breaking through the blood-brain barrier for different kinds of drugs: challenges, solutions, and perspectives
She, P., Ao, X., Zhan, X., Zhou, W., Cheng, Y., Yang, H. J., Wu, S., Zhang, X., Peng, W., & Wang, J. (2024) · BME Horizon · doi:10.70401/bmeh.2024.124 · Cited by 2
Review of Existing Method for Brain Delivery
Wang, Y., Li, Y., Li, W., & Yang, Y. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19393 · Cited by 1
Drug Treatment Direction Based on the Molecular Mechanism of Breast Cancer Brain Metastasis
Zhang, Y., Shang, H., Zhang, J., Jiang, Y., Li, J., Xiong, H., & Chao, T. (2025) · Pharmaceuticals · doi:10.3390/ph18020262 · Cited by 2
Challenges and Opportunities in the Development of Nano-Structured Lipid Carriers for Brain Targeting
Nirmal, P., Singh, N., & Singh, R. P. (2025) · International Journal of Newgen Research in Pharmacy & Healthcare · doi:10.61554/ijnrph.v3i1.2025.140 · Cited by 1
Hydrogel‐based drug delivery systems for intracerebral hemorrhage with therapeutic advances and emerging roles of the bone–brain axis
Shi, H., Chen, M., Chen, Y., Li, M., Ma, J., Yin, Z., Li, W., Miao, Y., Ou, Z., Wu, K., et al. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70138 · Cited by 1
Carbohydrate-Functionalized Liposomal Nanocarriers: Design Strategies for Receptor-Mediated Organ Targeting and Advanced Theranostic Applications
Beliraya, J., Seenivasan, R., Halagali, P., Rathnanand, M., & Tippavajhala, V. K. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03453-z · Cited by 2
Impact of Obstructive Sleep Apnea on Blood–Brain Barrier Permeability and Membrane Proteins
Jarecki, D., Turkiewicz, S., Białasiewicz, P., Strzelecki, D., & Gabryelska, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156702 · Cited by 1
Ex vivo nanoscale abluminal mapping of putative cargo receptors at the blood-brain barrier of expanded brain capillaries
Holst, M. R., Richner, M., Arenshøj, P. O., Alam, P., Hyldig, K., & Nielsen, M. S. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00585-x · Cited by 1
Current Perspectives of Nanotherapeutics for the Treatment of Alzheimer’s Disease
Mishra, S., Senthilkumar, D., & Yadav, V. K. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815256505124010010 · Cited by 1
The Guardian of the Brain: Understanding the Blood–Brain Barrier and its Role in CNS Drug Discovery
Rohfleisch, L., & Mishuris, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-61992-2_5 · Cited by 1
4.30 Nanomaterials for Drug Delivery to the Brain
Gaudin, A., Seo, Y.-E., Song, E., Quijano, E., King, A. R., & Saltzman, W. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.09288-2 · Cited by 1
Altered Biodistribution and Tissue Retention of Nanoparticles Targeted with P-Glycoprotein Substrates
Crawford, L., Watkins, H. C., Wayne, E. C., & Putnam, D. A. (2019) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-019-00111-8 · Cited by 1
Nanoparticles beyond the blood-brain barrier for glioblastoma
Jena, L., Dunne, N., & McCarthy, H. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00027-0 · Cited by 1
Systemic ligand-mimicking bioparticles cross the blood-brain barrier and reduce growth of intracranial triple-negative breast cancer using the human epidermal growth factor receptor 3 (HER3) to mediate both routesPreprint
Alonso-Valenteen, F., Sances, S., Wang, H., Mikhael, S., Sims, J. D., Taguiam, M., Srinivas, D., Serrano, E., Ondatje, B. N., Teh, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.07.446634 · Cited by 1
A Human Brain-Chip for modelling brain pathologies and screening of BBB crossing therapeutic strategiesPreprint
Chim, S. M., Howell, K., Kokkosis, A. G., Zambrowicz, B., Karalis, K. P., & Pavlopoulos, E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.11.607509 · Cited by 1
The link between ceramide transporters, innate immunity and Alzheimer’s disease
Bode, G. H. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161014gb
Nanotherapy for Early Dementia: Targeting Senile EndotheliumPreprint
D'Arrigo, J. S. (2017) · Preprints.org · doi:10.20944/preprints201709.0050.v1
Initial development of an implantable drug delivery device for the treatment of epilepsy
Bauquier, S. H. (2018) · Minerva Access (University of Melbourne)
Principles of Neuropharmacodynamics: As Applied to Neuro-Oncology
Rodgers, A. H. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82653
Nanotherapy for Alzheimer's Disease and Vascular Dementia: Targeting Senile EndotheliumPreprint
D'Arrigo, J. S. (2017) · SSRN Electronic Journal · doi:10.2139/ssrn.3041744
Transferrin receptor-mediated gene delivery using functionalised gold nanoparticles.
Padayachee, J. (2018) · ResearchSpace (University of KwaZulu-Natal)
Novel Diagnostic and Therapeutic Immunologic Strategies to Overcome Infectious, Oncologic and Neurodegenerative Disorders
Aires‐da‐Silva, F., Dias, J., Aguiar, S. I., Marques, F., André, A., Gil, S., & Tavares, L. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-61981-7_24
Drug nanotargeting for treatment of neurodegeneration and aging
D'Arrigo, J. S. (2021) · Aging Pathobiology and Therapeutics · doi:10.31491/apt.2021.06.053
Transcytosis-inducing biomaterials for actively translocating nanomedicines
Xu, L., Zhou, Q., Shao, S., & Shen, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822425-0.00021-x
Faculty Opinions recommendation of Transferrin receptor targeting by de novo sheet extension.
Okada, T. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739970477.793585940
Molecular Identity Changes of Tumor-Associated Macrophages and Microglia after MRgFUS induced BBB Opening in a Mouse Glioblastoma ModelPreprint
Zhang, Y., Wang, J., Ghobadi, S. N., Zhou, H., Huang, A., Gerosa, M., Hou, Q., Keunen, O., Golebiewska, A., Habte, F. G., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1437061/v1
Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics
Jadhav, S. S., Yenorkar, N. Y., Bondre, R. M., Karemore, M. N., & Bali, N. R. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103315
Nanotherapy for Early Dementia: Targeting Senile DementiaPreprint
D'Arrigo, J. S. (2017) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3vysu
Desenvolvimento de sistemas lipossomais para a liberação da alfa-glicosidase como proposta para a terapia da doença de Pompe
Caron, A. L. (2021) · doi:10.11606/t.60.2021.tde-27092021-152105
Approaches Towards Prediction of CNS PK and PD
de Lange, E. C. M., Chang, H. Y., & Shah, D. K. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_12
Multifunctional Polymeric Nanocarriers for Targeted Brain Delivery
Zhang, Z., & Lampe, K. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-11409-0_7
Taking Advantages of Blood–Brain Barrier to Optimize Delivery of Drugs in Central Neurological ConditionsPreprint
Hou, Y., Fang, Y., Wu, K., Song, Y., Liu, K., Zhu, J., & Zheng, X. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4661733
Design and synthesis of biocompatible magnetic ferrite nanoparticles conjugated with Angiopep for LRP-1 receptor-mediated delivery
Mokhosi, S. R., Mdlalose, W. B., & Singh, M. (2023) · NANOCOM ... · doi:10.37904/nanocon.2023.4758
Additional file 1 of Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
Holst, M. R., de Wit, N. M., Ozgür, B., Brachner, A., Hyldig, K., Appelt‐Menzel, A., Sleven, H., Cader, M. Z., de Vries, H. E., Neuhaus, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24515905
Therapeutic strategies based on genetic interventions
Baek, R. C., Finn, P. F., & Martini, P. G. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99417-0.00013-6
Analysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
Chaves, J. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.248279
Nervous System, Neurons, and Metabolism
Konukoğlu, D. (2024) · doi:10.69860/nobel.9786053359166.1
The blood–brain barrier: Gatekeeper and obstacle in neurodegenerative disorders
Bassiony, M., Ibrahem, M. A., Youssef, D. G., Elbadry, A. M. M., & Alaboudi, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00002-6
Nonclinical development of monovalent and polyvalent biopharmaceuticals
Staflin, K., Korgaonkar, C. K., Narayanan, P. K., Prell, R. A., Lee, D. W., Halpern, W., & Connor, A. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00008-0
Nanoparticle-mediated drug delivery for neurodegenerative diseases
Parhi, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00013-1
Nanotherapy for Early Dementia: Targeting Senile DementiaPreprint
D'Arrigo, J. S. (2017) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3vysu_v1
The Blood-Brain Barrier Disruption Methods for Drug Delivery
Amini, M., & Banu, M. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-80173-0_5
The path towards precision medicine: Next generation biotherapeutics and delivery strategies across the blood–brain barrier for the treatment of neurodegenerative diseases
Sandhu, J. K., Thakur, K., Cai, D., Péladeau, C. L., Hewitt, M., & Ghadban, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00055-3 · Cited by 1
Polymeric nanoparticulate carrier(s) for brain tumor therapy
Pourmadadi, M., Parvaneh, S., & Mahmoodi, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33319-4.00003-3
Brendo: an open resource for uniquely transcribed genes in brain endothelial cellsPreprint
Beker, O., Khorsand, F. R., Adebalı, O., & Mustafaoğlu, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.25.684508
Additional file 2 of Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
Holst, M. R., de Wit, N. M., Ozgür, B., Brachner, A., Hyldig, K., Appelt‐Menzel, A., Sleven, H., Cader, Z., de Vries, H. E., Neuhaus, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24516076
A fully human pluripotent stem cell-derived blood-brain barrier model for clinically relevant disease modeling and selection of neurotropic adeno-associated virusesPreprint
Iannielli, A., Giannelli, S. G., Behrens, T., Luoni, M., Muggeo, S., Moscato, G., Greco, M., Enzi, E., Khoury, R. E., Criscuolo, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.21.695793
RNA-based approaches for neuroprotection and recovery in ischemic stroke: current evidence and future directions
Aderinto, N., Babawale, E. A., Olatunji, G. D., Kokori, E., Babarinde, F. O., Donaldy, W., Oyesiji, O. W., Vande-Pallen, F. V., Andibanbang, F., Obaje, A. A., et al. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01094-4
Decoding the implicit paradigm of exosome targeting blood brain barrier in neurodegenerative diseases: Molecular insight and therapeutic perspective
Koley, R., De, S., Ghosh, A., Bhattacharjee, D., Mitra, A., Mondal, B., Pahari, A., Nandi, M., Kanri, R., Dasgupta, S., et al. (2026) · In vitro models · doi:10.1007/s44164-026-00111-3
Mise en place de modèles in vitro de barrière hémato‐encéphalique et étude du transfert transendothélial de vecteurs et conjugués ciblant le récepteur au LDL
Molino, Y. (2015) · theses.fr (ABES) · doi:10.70675/f175f606z0859z4408za980z63d112229176
Trafic intracellulaire de peptide-vecteurs ciblant le récepteur au LDL pour des stratégies de délivrance ciblée d'agents thérapeutiques ou d'imagerie à travers la barrière hémato-encéphalique
Varini, K. (2015) · theses.fr (ABES) · doi:10.70675/e8921266z6906z4421z8181z90a4f135bf9f
Potentialisation des chimiothérapies dans le traitement du glioblastome : étude des transporteurs ABC et ouverture de la barrière hémato-encéphalique par ultrasons
Dréan, A. (2018) · theses.fr (ABES) · doi:10.70675/4f15a9f7z92e6z4973z9e0bz065b3edec352
Targeting the NLRP3 inflammasome with antibody-based therapeutics for chronic neurodegenerative diseases
Sandhu, J. K., Tanha, J., & Arbabi‐Ghahroudi, M. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671675 · Cited by 1
Leveraging engineered small EVs to mitigate cancer pain: a new paradigm
Sarkar, S., Roy, S., & Choudhury, L. (2026) · Journal of Microencapsulation · doi:10.1080/02652048.2026.2677813
Nanocarrier enabled and Immuno responsive therapeutic platforms for targeted drug delivery and disease modification in Parkinson’s disease
Guduru, K. K., Ravi, G., & Bhargav, E. (2026) · Discover Applied Sciences · doi:10.1007/s42452-026-08947-w
Lipid-based nanocarriers for Alzheimer's disease: Design strategies, targeting mechanisms, and therapeutic performance
Yusuf, A., Harati, R., Greish, K., & Haider, M. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108594
A barrier-crossing and immune checkpoint-blocking antibody fusion protein for enhanced glioma-targeted immunotherapy
Bao, Y., Yang, S., Ding, Y., Zhou, J., Zheng, X., Chen, R., Jiang, Z., Meng, N., Pan, D., Lu, J., et al. (2026) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2026.101175
Biopolymer-based Therapeutic Approaches as Effective Treatment Methods for Alzheimer's Disease
Karati, D., & Meur, S. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010016
Targeting the vascular interface: beyond crossing the blood-brain barrier
Sadaqa, E., & Hanafy, A. S. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115323
Topology- and sequence-controlled β-amyloid recognition by a KLVFF/transferrin-functionalized csq porphyrinic zirconium MOF (PCN-222)
Xiao, C., & Wei, H. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1906393
Lactoferrin and Nanotechnology: New Insights Into Glioblastoma Therapy
Abed, A., & Mahabadi, J. A. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71070
Future directions in Parkinson's disease pharmacotherapy
Abo‐elnour, D. E., Helal, M. M., Ahmed, B. A., Abouelmagd, M. E., Hefnawy, M. T., Alsalhi, H. K., Abdelkader, A., Al-dardery, N. M., & Alshwayyat, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27702-3.00025-x
A Bioengineered Tf‐Directed Magnetic Mesoporous PCL Nanoplatform for Potent Doxorubicin‐Mediated Glioma Treatment
Ramesh, S., Heggannavar, G. B., Patil, S. L., Durgannavar, A. K., & Kariduraganavar, M. Y. (2026) · Journal of Applied Polymer Science · doi:10.1002/app.71647

Authors: Lajoie, J. M., & Shusta, E. V.
Affiliations: University of Wisconsin–Madison (US)
ORCID: Shusta, Eric V.
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2015-01-06
Volume: 55
Issue: 1
Pages: 613-631
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev-pharmtox-010814-124852
PMC: PMC5051266
OpenAlex: W2169055592
Cited by: 399
References: 124
Citations by year: 2026: 23 · 2025: 35 · 2024: 43 · 2023: 41 · 2022: 52 · 2021: 49 · 2020: 42 · 2019: 30 · 2018: 36 · 2017: 22 · 2016: 21 · 2015: 5
FWCI: 1.29
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Human Genome Research Institute (T32HG002760)
National Institute of General Medical Sciences (T32GM008349)
National Institute of Neurological Disorders and Stroke (R01NS071513)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: blood-brain barrier, receptor-mediated transport, biologics, BBB crossing, vesicle trafficking, targeting ligands, neurological disorders, Alzheimer's disease, stroke, multiple sclerosis
MeSH terms: Animals, Biological Products, Biological Transport, Blood-Brain Barrier, Capillary Permeability, Chemistry, Pharmaceutical, Drug Carriers, Humans, Receptors, Cell Surface, Technology, Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks